Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

raztopina za infundiranje - albumin

Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

infuzija - albumin

Europeiska unionen - slovenska - EMA (European Medicines Agency)

stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastična sredstva - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).

Europeiska unionen - slovenska - EMA (European Medicines Agency)

ab science s.a. - masitinib mesilate - antineoplastična sredstva - psi - zdravljenje neresetabilnih tumorjev mastocitov (razred 2 ali 3) s potrjenim mutiranim c-kit tirozin-kinaznim receptorjem.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

janssen-cilag international n.v.    - amivantamab - karcinom, pljučni pljuč - antineoplastična sredstva - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

zoetis belgium sa - toceranib - antineoplastična sredstva - psi - zdravljenje nerazprtega zdravila patnaik razred-ii (vmesni razred) ali -iii (visokokakovostnih), ponavljajočih, tumorjev tumorja mastocitov pri psih.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - irbesartan - hipertenzija - sredstva, ki delujejo na sistem renin-angiotenzin - zdravljenje esencialne hipertenzije. zdravljenje ledvične bolezni pri bolnikih s hipertenzijo in tip 2 sladkorna bolezen kot del antihypertensive zdravila režim (glej poglavje 5.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

otsuka novel products gmbh - delamanid - tuberkuloza, odporna proti multidrugom - antimikobakterij - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 in 5. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Europeiska unionen - slovenska - EMA (European Medicines Agency)

astrazeneca ab - moxetumomab pasudotox - leukemija, dlakasta celica - antineoplastična sredstva - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).

Slovenien - slovenska - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - ceftriakson - prašek za raztopino za injiciranje/infundiranje - ceftriakson 1 g / 1 viala - ceftriakson